The table below summarizes the most recent Sabra Health Care REIT insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Sabra Health Care REIT insider buys are important for investors to follow.

Date	Insider	Price	Amount
9-1-2023 Insider Buy	Michael Lourenco Costa Executive VP, CFO & Secretary	$12.63 CAGR »	$24,590.61 1,947 shares
2-25-2022 Insider Buy	Catherine Cusack Director	$13.24 CAGR »	$26,480.00 2,000 shares
3-2-2021 Insider Buy	Catherine Cusack Director	$17.34 CAGR »	$17,340.00 1,000 shares
3-16-2020 Insider Buy	Michael J. Foster Director	$7.72 CAGR »	$99,429.08 12,875 shares
12-8-2015 Insider Buy	Michael J. Foster Director	$19.86 CAGR »	$99,290.50 5,000 shares
11-13-2015 Insider Buy	Milton J. Walters Director	$19.80 CAGR »	$49,500.00 2,500 shares
6-15-2015 Insider Buy	Robert A. Ettl Director	$25.49 CAGR »	$50,980.00 2,000 shares
6-9-2015 Insider Buy	Michael J. Foster Director	$25.29 CAGR »	$128,321.46 5,074 shares
5-7-2015 Insider Buy	Robert A. Ettl Director	$27.95 CAGR »	$97,825.00 3,500 shares
2-20-2015 Insider Buy	Milton J. Walters Director	$32.52 CAGR »	$81,289.25 2,500 shares
8-9-2013 Insider Buy	Craig A. Barbarosh Director	$24.99 CAGR »	$24,989.00 1,000 shares
5-30-2013 Insider Buy	Robert A. Ettl Director	$27.80 CAGR »	$55,600.00 2,000 shares
11-23-2011 Insider Buy	Craig A. Barbarosh Director	$9.99 CAGR »	$9,990.00 1,000 shares

Also See: Institutional Holders of SBRA
Also See: SEC filings

Below we present the annualized performance delivered by Sabra Health Care REIT stock since 9-1-2023 (the date of the most recent insider purchase). The performance of the investment from the time Sabra Health Care REIT insider buying occurred is the ultimate test of whether insiders were right about SBRA being a good buy.

Growth of $10,000.00 With Dividends Reinvested
Start date:	09/05/2023
End date:	05/01/2024
Start price/share:	$12.61
End price/share:	$13.93
Starting shares:	793.02
Ending shares:	827.63
Dividends reinvested/share:	$0.60
Total return:	15.29%
Annualized Gain:	23.35%
Starting investment:	$10,000.00
Ending investment:	$11,529.00
Years:	0.65

Growth of $10,000.00 Without Dividends Reinvested
Start date:	09/05/2023
End date:	05/01/2024
Start price/share:	$12.61
End price/share:	$13.93
Dividends collected/share:	$0.60
Total return:	15.23%
Annualized Gain:	23.25%
Starting investment:	$10,000.00
Ending investment:	$11,523.00
Years:	0.65

Sabra Health Care REIT Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Sabra Health Care REIT insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding SBRA

SBRA — Current Quote

Quotes delayed 20 minutes

Free SBRA Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

SBRA — Performance

More Insider Buying

Other companies seeing insider buying close in time to when the Sabra Health Care REIT Insider Buying occurred are:

Xponential Fitness Insider Buying
Rapid Micro Biosystems Insider Buying
TreeHouse Foods Insider Buying
ACNB Insider Buying
Cardio Diagnostics Holdings Insider Buying
Vicor Insider Buying
Hormel Foods Insider Buying
Douglas Dynamics Insider Buying
Lamar Advertising Co (New) Insider Buying
Catalent Insider Buying

Sabra Health Care REIT Insider Buying

Sabra Health Care REIT Insider Buying | www.HoldingsChannel.com